Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 9/20 | 0.56 |
| ▸ | GRIK2 | Q13002 | 5/20 | 0.56 |
| ▸ | GRIA2 | P42262 | 2/20 | 0.41 |
| ▸ | GRIA4 | P48058 | 2/20 | 0.41 |
| ▸ | GRIK3 | Q13003 | 2/20 | 0.41 |
| ▸ | GRIK5 | Q16478 | 2/20 | 0.41 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2139638 | 1.00 | GRIK1 (0.56) | GRIK1GRIK2GRIA2GRIA4GRIK3 | |
| SCHEMBL5707879 | 0.83 | GRIK1 (0.39) | GRIK1GRIK2GRIA2GRIA4GRIK3 | |
| SCHEMBL10450348 | 0.82 | GRIK1 (0.58) | GRIK1GRIK2GRIA2GRIA4GRIK3 | |
| SCHEMBL3620136 | 0.82 | GRIK1 (0.58) | GRIK1GRIK2GRIA2GRIA4GRIK3 | |
| SCHEMBL8377796 | 0.82 | GRIK1 (0.58) | GRIK1GRIK2GRIA2GRIA4GRIK3 | |
| SCHEMBL320056 | 0.81 | GRIK1 (0.38) | GRIK1GRIK2GRIA2GRIA4GRIK3 | |
| SCHEMBL10937503 | 0.81 | KDM4E (0.48) | GRIK1GRIK2GRIA2GRIA4GRIK3 | |
| SCHEMBL10937515 | 0.81 | KDM4E (0.48) | GRIK1GRIK2GRIA2GRIA4GRIK3 | |
| SCHEMBL11802504 | 0.81 | KDM4E (0.48) | GRIK1GRIK2GRIA2GRIA4GRIK3 | |
| SCHEMBL10942638 | 0.79 | GRIK1 (0.52) | GRIK1GRIK2GRIA2GRIA4GRIK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2601229-B1 | GRAFT COPOLYMERS OF POLYFARNESENES WITH CONDENSATION POLYMERS | AMYRIS INC (US) | 2013-10-16 | — | — | EP | claimed |
| EP-2812392-B1 | BEARING SURFACE MIXTURE CONTAINING MICRO-GEL FOR WINTER TYRES | ARLANXEO DEUTSCHLAND GMBH (DE) | 2018-08-22 | — | — | EP | disclosed |
| CN-105008478-B | Double-sided adhesive sheet | 琳得科株式会社 | 2018-06-05 | — | — | CN | disclosed |
| EP-2812392-A1 | MICROGEL-CONTAINING TREAD MIXTURE FOR WINTER TYRES | Lanxess Deutschland GmbH (DE) | 2014-12-17 | — | — | EP | disclosed |
| WO-2013117762-A1 | MICROGEL-CONTAINING TREAD MIXTURE FOR WINTER TYRES | LANXESS DEUTSCHLAND GMBH (DE) | 2013-08-15 | — | — | WO | disclosed |
| US-20110006245-A1 | POLYMER COATED INORGANIC FINE PARTICLE AND METHOD FOR PREPARING THE SAME | TAMAGAWA SEIKI CO., LTD. (JP) | 2011-01-13 | — | — | US | disclosed |
| EP-2221327-A1 | POLYMER-COATED FINE INORGANIC PARTICLE AND PROCESS FOR PRODUCING THE SAME | Handa, Hiroshi (JP) | 2010-08-25 | — | — | EP | disclosed |
| WO-2001044333-A1 | THERMOSETTING RESIN OBTAINED BY REACTION OF A TRIAZINE COMPOUND WITH AN ALDEHYDE AND AN ACTIVATED OLEFINIC COMPOUND | DSM N.V. (NL) | 2001-06-21 | — | — | WO | disclosed |
| EP-0632127-A1 | Use of colostrum or mother's milk to inhibit the accumulation of proteins on the surface of synthetic polymers used in contact with biological systems; application in the care of contact lenses | ESSILOR INTERNATIONAL COMPAGNIE GENERALE D'OPTIQUE (FR) | 1995-01-04 | — | — | EP | disclosed |
| US-4323363-A | DISPERSE DYE USED ON POLYESTERS MIXED WITH CELLULOSE | CASSELLA AKTIENGESELLSCHAFT (DE) | 1982-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110006245-A1 | POLYMER COATED INORGANIC FINE PARTICLE AND METHOD FOR PREPARING THE SAME | CYP4F12, CYP2F1, CYP4F3 | GRIK1 2424/4885GRIK2 1446/4885GRIA2 465/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.